Back
Frontier Group Holdings Vs. Aligos Therapeutics Industry Stock Comparison
Buy
55
ULCC
Frontier Group Holdings
Last Price:
$6.77
Seasonality Move:
1.95%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$39.49
Seasonality Move:
7.18%
Buy
55
Frontier Group Holdings (ULCC)
is a Buy
Is Frontier Group Holdings a Buy, Sell or Hold?
-
The current Frontier Group Holdings [ULCC] share price is $6.43. The Score for ULCC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ULCC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ULCC Stock Price Chart
What is Frontier Group Holdings's stock price today?
-
The Frontier Group Holdings share price today is $6.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ULCC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ULCC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 54.58 | Buy |
Chaikin Money Flow: | 1458465 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.6 - 6.46) | Buy |
Bollinger Bands (100): | (3.85 - 6.41) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.1 | Buy |
Relative Strength Index (14 RSI): | 79.33 | Buy |
Chaikin Money Flow: | 265554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.3 - 32.5) | Buy |
Bollinger Bands (100): | (7.16 - 22.66) | Buy |
ULCC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.39 | Buy |
20-day SMA: | 6.04 | Buy |
50-day SMA: | 6.22 | Buy |
200-day SMA: | 5.48 | Buy |
8-day EMA: | 6.31 | Buy |
20-day EMA: | 6.18 | Buy |
50-day EMA: | 5.95 | Buy |
200-day EMA: | 5.61 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Buy |
20-day SMA: | 28.23 | Buy |
50-day SMA: | 17.95 | Buy |
200-day SMA: | 16.14 | Buy |
8-day EMA: | 33.62 | Buy |
20-day EMA: | 28.8 | Buy |
50-day EMA: | 21.66 | Buy |
200-day EMA: | 17.2 | Buy |
Frontier Group Holdings Earnings Growth & ULCC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.47 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Frontier Group Holdings Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |